Xia Yuan, Zhou Haiyun, Ou Jing-Song, Liu Yunqi
Division of Cardiac Surgery, Cardiovascular Diseases Institute, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou 510080, China.
Department of Cardiac Surgery, The First Affiliated Hospital, Guangzhou Medical University, Guangzhou 510160, China.
Bioengineering (Basel). 2024 Jul 10;11(7):700. doi: 10.3390/bioengineering11070700.
Small-diameter vascular grafts (SDVGs) are severely lacking in clinical settings. Therefore, our study investigates a new source of biological vessels-bovine and porcine decellularized intercostal arteries (DIAs)-as potential SDVGs. We utilized a combination of SDS and Triton X-100 to perfuse the DIAs, establishing two different time protocols. The results show that perfusing with 1% concentrations of each decellularizing agent for 48 h yields DIAs with excellent biocompatibility and mechanical properties. The porcine decellularized intercostal arteries (PDIAs) we obtained had a length of approximately 14 cm and a diameter of about 1.5 mm, while the bovine decellularized intercostal arteries (BDIAs) were about 29 cm long with a diameter of approximately 2.2 mm. Although the lengths and diameters of both the PDIAs and BDIAs are suited for coronary artery bypass grafting (CABG), as the typical diameter of autologous arteries used in CABG is about 2 mm and the grafts required are at least 10 cm long, our research indicates that BDIAs possess more ideal mechanical characteristics for CABG than PDIAs, showing significant potential. Further enhancements may be necessary to address their limited hemocompatibility.
小口径血管移植物(SDVGs)在临床应用中严重短缺。因此,我们的研究探索了一种新的生物血管来源——牛和猪的去细胞化肋间动脉(DIAs)——作为潜在的小口径血管移植物。我们使用十二烷基硫酸钠(SDS)和 Triton X - 100 的组合对肋间动脉进行灌注,建立了两种不同的时间方案。结果表明,用 1%浓度的每种去细胞化试剂灌注 48 小时可获得具有优异生物相容性和机械性能的去细胞化肋间动脉。我们获得的猪去细胞化肋间动脉(PDIAs)长度约为 14 厘米,直径约为 1.5 毫米,而牛去细胞化肋间动脉(BDIAs)长约 29 厘米,直径约为 2.2 毫米。尽管猪和牛的去细胞化肋间动脉的长度和直径都适合冠状动脉旁路移植术(CABG),因为冠状动脉旁路移植术中使用的自体动脉的典型直径约为 2 毫米,所需移植物至少 10 厘米长,但我们的研究表明,对于冠状动脉旁路移植术而言,牛去细胞化肋间动脉比猪去细胞化肋间动脉具有更理想的机械特性,显示出巨大潜力。可能需要进一步改进以解决其有限的血液相容性问题。